Product logins

Find logins to all Clarivate products below.


Breast Implants and Reconstructive Devices | Market Insights | Europe (Supplemental) | 2023

While the European breast implant and reconstructive device market saw a significant impact in 2020 due to COVID-19 pandemic, procedure volumes recovered vaccination campaigns rolled out and restrictions were eased. Beyond the impact of the pandemic, the European market for breast implant and reconstructive devices will exhibit modest growth through 2031 driven by growing aesthetic consciousness, availability of innovative technologies, and volume discounts on products to support product sales.

This Medtech 360 Report provides high-level market metrics for breast implants and reconstructive devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2031.

Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Europe
The European TEO device market is projected to experience modest growth over the forecast period, driven by increasing adoption of minimally invasive procedures. The trend is further supported by…
Report
Sports Medicine Devices – Market Insights – Europe
The Europe sports medicine device market will grow modestly through 2034, driven by growing demand for sports medicine procedures, uptake of premium-priced products, increased availability and…